Fox Run Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Fox Run Management's AMPH Position: Q2 2026 in Review
Fox Run Management opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 14,556 shares worth $294K. The stake represents 0.05% of the portfolio and ranks #680 among its holdings. This is a return to the name: Fox Run Management previously reported a position in AMPH as recently as Q2 2025.
Fox Run Management first reported a position in AMPH in Q4 2016 and has held it in 6 quarters since. The position peaked at $688K in Q4 2024. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Fox Run Management held 14,556 shares of Amphastar Pharmaceuticals worth $294K as of Q2 2026.
- Amphastar Pharmaceuticals was a new Fox Run Management position in Q2 2026.
- Amphastar Pharmaceuticals made up 0.05% of Fox Run Management's portfolio in Q2 2026, its #680 holding.
- Fox Run Management first reported a position in Amphastar Pharmaceuticals in Q4 2016 and has held it in 6 quarters since.
- Fox Run Management's Amphastar Pharmaceuticals position peaked at $688K in Q4 2024.
- 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.